MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 100 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $176,000 | -12.9% | 61,443 | +204.5% | 0.21% | +14.4% |
| Q3 2018 | $202,000 | +117.2% | 20,180 | +54.0% | 0.19% | +466.7% |
| Q2 2018 | $93,000 | -8.8% | 13,105 | -51.1% | 0.03% | -70.3% |
| Q1 2018 | $102,000 | -32.9% | 26,827 | +43.9% | 0.11% | -40.0% |
| Q4 2017 | $152,000 | +60.0% | 18,643 | +15.1% | 0.18% | +90.7% |
| Q3 2017 | $95,000 | – | 16,198 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,042,735 | $14,473,000 | 4.95% |
| VHCP Management III, LLC | 1,258,964 | $3,613,000 | 2.63% |
| Granite Point Capital Management, L.P. | 2,659,367 | $7,632,000 | 1.54% |
| Granite Point Capital Management, L.P. | 1,600,000 | $4,592,000 | 0.93% |
| VHCP Management II, LLC | 743,876 | $2,135,000 | 0.92% |
| Monashee Investment Management LLC | 250,000 | $718,000 | 0.49% |
| 683 Capital Management, LLC | 1,350,000 | $3,875,000 | 0.24% |
| CAXTON CORP | 61,443 | $176,000 | 0.21% |
| Tekla Capital Management LLC | 755,776 | $2,169,000 | 0.09% |
| Fosun International Ltd | 491,997 | $1,378,000 | 0.08% |